N, K., A, S., B, W., P, K., X, H., AHF, R., . . . D, O. (2024). Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways. Nature communications, 15(1), 10698. https://doi.org/10.1038/s41467-024-55044-w
Chicago Style (17th ed.) CitationN, Kurmasheva, et al. "Author Correction: Octyl Itaconate Enhances VSVΔ51 Oncolytic Virotherapy by Multitarget Inhibition of Antiviral and Inflammatory Pathways." Nature Communications 15, no. 1 (2024): 10698. https://doi.org/10.1038/s41467-024-55044-w.
MLA (9th ed.) CitationN, Kurmasheva, et al. "Author Correction: Octyl Itaconate Enhances VSVΔ51 Oncolytic Virotherapy by Multitarget Inhibition of Antiviral and Inflammatory Pathways." Nature Communications, vol. 15, no. 1, 2024, p. 10698, https://doi.org/10.1038/s41467-024-55044-w.